![Jonathan Sporn](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jonathan Sporn
Fundador en Gilgamesh Pharmaceuticals, Inc. .
Cargos activos de Jonathan Sporn
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Gilgamesh Pharmaceuticals, Inc.
![]() Gilgamesh Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gilgamesh Pharmaceuticals, Inc. engages in the development of drugs for the treatment of neuropsychiatric conditions including depression, anxiety, substance use, and stress-related disorders. Its products pipeline include Arylcyclohexylamine, Serotonergic Micro-Dose, and Novel Ibogaine Analogue. The company was founded by Jonathan Sporn, Dalibor Sames, Andrew Kruegel, Jeff Witkin, and Mike Cunningham and is headquartered in New York, NY. | Director/Miembro de la Junta | - | - |
Director Ejecutivo | - | - | |
Fundador | - | - | |
Presidente | - | - |
Historial de carrera de Jonathan Sporn
Antiguos cargos conocidos de Jonathan Sporn.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Perception Neuroscience, Inc.
![]() Perception Neuroscience, Inc. Medical/Nursing ServicesHealth Services Perception Neuroscience, Inc. operates as a biopharmaceutical company, focusing on developing therapies in Neuropsychiatry. The company was founded by Jonathan Sporn and Jay Kranzler and is headquartered in New York, NY. | Fundador | - | - |
Estadísticas
Internacional
Estados Unidos | 3 |
Operativa
Founder | 2 |
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Sectorial
Health Services | 2 |
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Perception Neuroscience, Inc.
![]() Perception Neuroscience, Inc. Medical/Nursing ServicesHealth Services Perception Neuroscience, Inc. operates as a biopharmaceutical company, focusing on developing therapies in Neuropsychiatry. The company was founded by Jonathan Sporn and Jay Kranzler and is headquartered in New York, NY. | Health Services |
Gilgamesh Pharmaceuticals, Inc.
![]() Gilgamesh Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gilgamesh Pharmaceuticals, Inc. engages in the development of drugs for the treatment of neuropsychiatric conditions including depression, anxiety, substance use, and stress-related disorders. Its products pipeline include Arylcyclohexylamine, Serotonergic Micro-Dose, and Novel Ibogaine Analogue. The company was founded by Jonathan Sporn, Dalibor Sames, Andrew Kruegel, Jeff Witkin, and Mike Cunningham and is headquartered in New York, NY. | Health Technology |
- Bolsa de valores
- Insiders
- Jonathan Sporn
- Experiencia